Moreover, DNA methylation changes interact with MED12 mutations to form a regulatory network that modulates progesterone receptor (PR) mediated RANKL expression, promoting stem cell proliferation and tumor growth [19,20,21]. This evidence concerns the gene MED12 and neoplasm.